312 related articles for article (PubMed ID: 2888663)
1. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.
Feelisch M; Noack EA
Eur J Pharmacol; 1987 Jul; 139(1):19-30. PubMed ID: 2888663
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a correlation between nitric oxide formation by cleavage of organic nitrates and activation of guanylate cyclase.
Schröder H; Noack E; Müller R
J Mol Cell Cardiol; 1985 Sep; 17(9):931-4. PubMed ID: 2864457
[TBL] [Abstract][Full Text] [Related]
3. Explanation of the discrepancy between the degree of organic nitrate decomposition, nitrite formation and guanylate cyclase stimulation.
Feelisch M; Noack E; Schröder H
Eur Heart J; 1988 Jan; 9 Suppl A():57-62. PubMed ID: 2900766
[TBL] [Abstract][Full Text] [Related]
4. [Thiol-dependent activation of guanylate cyclase by organic nitrates].
Schröder H; Noack E
Z Kardiol; 1986; 75 Suppl 3():20-4. PubMed ID: 2879391
[TBL] [Abstract][Full Text] [Related]
5. Guanylate cyclase activation by organic nitrates is not mediated via nitrite.
Romanin C; Kukovetz WR
J Mol Cell Cardiol; 1988 May; 20(5):389-96. PubMed ID: 2905390
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of nitrovasodilator bioactivation.
Noack E; Feelisch M
Basic Res Cardiol; 1991; 86 Suppl 2():37-50. PubMed ID: 1683227
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of organic nitrates for activation of guanylate cyclase.
Schröder H; Noack E
Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):235-46. PubMed ID: 2895614
[TBL] [Abstract][Full Text] [Related]
8. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite.
Gruetter CA; Kadowitz PJ; Ignarro LJ
Can J Physiol Pharmacol; 1981 Feb; 59(2):150-6. PubMed ID: 6112057
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.
Ignarro LJ; Lippton H; Edwards JC; Baricos WH; Hyman AL; Kadowitz PJ; Gruetter CA
J Pharmacol Exp Ther; 1981 Sep; 218(3):739-49. PubMed ID: 6115052
[No Abstract] [Full Text] [Related]
10. Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo.
Mülsch A; Bara A; Mordvintcev P; Vanin A; Busse R
Br J Pharmacol; 1995 Nov; 116(6):2743-9. PubMed ID: 8590999
[TBL] [Abstract][Full Text] [Related]
11. In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics.
Artz JD; Toader V; Zavorin SI; Bennett BM; Thatcher GR
Biochemistry; 2001 Aug; 40(31):9256-64. PubMed ID: 11478893
[TBL] [Abstract][Full Text] [Related]
12. Soluble guanylate cyclase activation by nitric oxide and its reversal. Involvement of sulfhydryl group oxidation and reduction.
Braughler JM
Biochem Pharmacol; 1983 Mar; 32(5):811-8. PubMed ID: 6132608
[TBL] [Abstract][Full Text] [Related]
13. Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans.
Feelisch M; Schönafinger K; Noack E
Biochem Pharmacol; 1992 Sep; 44(6):1149-57. PubMed ID: 1358072
[TBL] [Abstract][Full Text] [Related]
14. On the mechanism of NO release from sydnonimines.
Feelisch M; Ostrowski J; Noack E
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S13-22. PubMed ID: 2484692
[TBL] [Abstract][Full Text] [Related]
15. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols.
Ignarro LJ; Gruetter CA
Biochim Biophys Acta; 1980 Aug; 631(2):221-31. PubMed ID: 6105889
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of soluble coronary arterial guanylate cyclase by SIN-1.
Schmidt K; Kukovetz WR
Eur J Pharmacol; 1986 Mar; 122(1):75-9. PubMed ID: 2869962
[TBL] [Abstract][Full Text] [Related]
17. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.
Gruetter CA; Barry BK; McNamara DB; Gruetter DY; Kadowitz PJ; Ignarro L
J Cyclic Nucleotide Res; 1979; 5(3):211-24. PubMed ID: 39089
[TBL] [Abstract][Full Text] [Related]
18. The deactivation of soluble guanylyl cyclase by redox-active agents.
Dierks EA; Burstyn JN
Arch Biochem Biophys; 1998 Mar; 351(1):1-7. PubMed ID: 9500837
[TBL] [Abstract][Full Text] [Related]
19. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
Mülsch A; Busse R; Bassenge E
Eur J Pharmacol; 1988 Dec; 158(3):191-8. PubMed ID: 2908105
[TBL] [Abstract][Full Text] [Related]
20. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
